STAAR SURGICAL CO
No SEC Form 4 filings for $STAA in the last 30 days.
See all $STAA insider activity →Masimo and Staar Surgical appointed new executives amid prior deal and proxy turmoil. Masimo named Tim Benner president under Danaher ownership, succeeding Katie Szyman after Masimo’s $9.9B Danaher acquisition. Staar made Warren Foust permanent CEO after a failed $1.6B Alcon sale. Staar Q1 revenue rose to $93.5M; Q2 revenue expected over $90M.
STAAR SURGICAL CO (STAA) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.4 5 staa-ex10_4.htm EX-10.4 EX-10.4 Exhibit 10.4 STAAR SURGICAL COMPANY AMENDED AND RESTATED OMNIBUS EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE STAAR Surgical Company, a Delaware corporation, (the “ Company ”), pursuant to its Amended and Restated Omnibus Equity Incent
Staar Surgical appointed Warren Foust as permanent CEO and president. He has been interim co-CEO with Deborah Andrews since February after CEO Stephen Farrell left when Staar’s proposed $1.6 billion sale to Alcon fell through. Andrews will become executive vice president and keep CFO duties. Staar shares fell 3.2% to $23.34.
Over the past 7 days, alphai's AI scored 6 news stories mentioning STAA (STAAR SURGICAL CO). Coverage has skewed bullish: 1 bullish, 5 neutral, and 0 bearish.
Recent STAA coverage spans financial news, market movers and corporate actions.
Permanent CEO appointment after a failed deal, combined with rebound signals and Q2 revenue guidance, can reduce uncertainty and support near-term sentiment.
The filing is a new, company-specific equity-compensation structure that can affect near-term sentiment and executive retention expectations, but it is not a fundamental earnings or guidance change.
Leadership change is likely to affect investor sentiment and near-term governance expectations, but the article provides no new financial guidance or operational metrics.
Leadership transition is a near-term governance catalyst, but the article provides no new financial guidance or deal terms.
Leadership transition at STAAR is a near-term governance and execution catalyst, but the article provides no new financial targets or operational guidance.
alphai scores every news story that mentions STAA with an AI model for sentiment and relevance, and aggregates insider trades from STAAR SURGICAL CO's SEC EDGAR Form 4 filings. Figures refresh continuously.
Masimo and Staar Surgical appointed new executives amid prior deal and proxy turmoil. Masimo named Tim Benner president under Danaher ownership, succeeding Katie Szyman after Masimo’s $9.9B Danaher acquisition. Staar made Warren Foust permanent CEO after a failed $1.6B Alcon sale. Staar Q1 revenue rose to $93.5M; Q2 revenue expected over $90M.
4 min readSTAAR SURGICAL CO (STAA) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.4 5 staa-ex10_4.htm EX-10.4 EX-10.4 Exhibit 10.4 STAAR SURGICAL COMPANY AMENDED AND RESTATED OMNIBUS EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE STAAR Surgical Company, a Delaware corporation, (the “ Company ”), pursuant to its Amended and Restated Omnibus Equity Incent
2 min readStaar Surgical appointed Warren Foust as permanent CEO and president. He has been interim co-CEO with Deborah Andrews since February after CEO Stephen Farrell left when Staar’s proposed $1.6 billion sale to Alcon fell through. Andrews will become executive vice president and keep CFO duties. Staar shares fell 3.2% to $23.34.
2 min readSTAAR Surgical (NASDAQ: STAA) said its board appointed Warren Foust as president and CEO effective Aug. 4, 2026, adding him to the board. Deborah Andrews will become executive VP and keep the CFO role. The company also noted Alcon terminated a $1.6 billion merger in January after a shareholder vote failed.
4 min readSTAAR Surgical (NASDAQ:STAA) said its board appointed Warren Foust as President and CEO effective immediately, and named Deborah Andrews EVP while keeping her as CFO. Foust joined in 2023 and most recently served as President and COO since March 2025. Andrews has been interim Co-CEO since February 2026. The company cited a global search for permanent leadership.
2 min readSTAAR Surgical (NASDAQ: STAA) said its Board appointed Warren Foust as President and CEO and added him to the Board, effective Aug. 4, 2026. Deborah Andrews, currently Interim Co-CEO, will become Executive Vice President while continuing as CFO. The release cites Foust’s prior roles at STAAR and J&J and references strong first-half performance and EVO market momentum.
2 min readUS stocks and bonds fell after Cleveland Fed President Beth Hammack said inflation remains a key concern. Oil jumped as the US launched strikes on Iran and Iran retaliated, raising Strait of Hormuz flow risks. Tech sold off, while energy rose. Several companies moved on earnings and guidance, including ISRG, NFLX, IBM, and TRV.
7 min readFutures fell as a Moonshot AI model release triggered renewed chip and AI-capex concerns. S&P futures were down 0.8% and Nasdaq futures down 1.7% by 8:00am ET, with NVDA, AMZN and META among premarket decliners. JPM cited worries about hyperscalers’ AI spending. Autoliv, Intuitive Surgical, Netflix, Staar Surgical and SpaceX also fell on results or events.
6 min readWall Street Breakfast podcast covers SpaceX, Netflix, and Wayfair. SpaceX shares fell about 4.2% premarket after Starship launch was called off due to engine issues, with a possible early next week timing. Netflix premarket is lower after Q2 revenue rose 13.4% to $12.56B but missed by about $20M. Wayfair shares are down 2.7% ahead of a July 23-27 summer sale.
7 min readNetflix shares fell about 9% premarket after its quarterly results missed revenue expectations and its third-quarter guidance disappointed, despite an EPS beat. Intuitive Surgical dropped over 12% after caution on U.S. insurance plan changes. The article also cites declines for Regenxbio and Autoliv and notes S&P 500 and Nasdaq 100 futures down.
3 min read
